AIZ vs BMNR

Assurant (AIZ) shows mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score, limiting distress risk assessment. The stock trades above its Graham Number of $204.04 at $233.39, suggesting a modest premium, but below the analyst target of $259.33. Strong earnings growth (YoY +102.7%) and consistent earnings beat rates (3 of last 4 quarters) support valuation, yet weak technicals (10/100) and negative insider activity raise caution. Profitability metrics like ROE (15.41%) and low debt/equity (0.38) are positives, but liquidity concerns are evident in a weak current ratio (0.41) and quick ratio (0.15).

BMNR exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating deteriorating financial health. While revenue growth is explosive at 627.8%, it is decoupled from profitability, as evidenced by a catastrophic operating margin of -592.09% and an astronomical Price-to-Sales ratio of 712.25. The stock has experienced a massive technical collapse from a 52-week high of $161.00 to $22.14, suggesting a speculative bubble burst. Despite a strong current ratio and zero debt, the lack of earnings and poor deterministic scores make the current valuation unsustainable.